Difference between revisions of "Haruo Naito"
(→Further positions) |
|||
| Line 10: | Line 10: | ||
* on Duke University’s Fuqua Board of Visitors | * on Duke University’s Fuqua Board of Visitors | ||
* Vice President of the [[International Federation of Pharmaceutical Manufacturers and Associations]] (IFPMA) {{ref|2}} | * Vice President of the [[International Federation of Pharmaceutical Manufacturers and Associations]] (IFPMA) {{ref|2}} | ||
| − | |||
| − | |||
| − | |||
== Notes == | == Notes == | ||
#{{note|1}} EISAI Website [http://www.eisai.co.jp/enews/epdf20060222.pdf News] | #{{note|1}} EISAI Website [http://www.eisai.co.jp/enews/epdf20060222.pdf News] | ||
#{{note|2}} IBID | #{{note|2}} IBID | ||
Latest revision as of 12:52, 4 June 2007
Mr. Haruo Naito is President and CEO of Eisai Co., Ltd. of Japan.
He played a key role in the establishment of the Health Care Science Institute that focuses on analysis and solutions for the complex problems and issues of international human health care.
In April 1999, Mr. Naito was awarded an honorary CBE from the United Kingdom in recognition of his long-standing efforts in strengthening U.K. - Japan relations [1].
Further positions
- on Northwestern University’s Kellogg Advisory Board
- on Duke University’s Fuqua Board of Visitors
- Vice President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) [2]
